The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.
Below is a clickable Heat Map of the 1 symbols on this page. The percent change is based on Friday's prices. Each symbol is a hyperlink or shortcut to more information.AMGN 0.76%
Market Cap 131 Billion
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).
EPS 3.29 P/E Ratio 15.15
Previous Tue, Jul 30, 2019
Latest Tue, Oct 29, 2019 (17 days ago) Price +7.24%
Yield 2.64% / $5.80
Ex-Date Thu, Nov 14, 2019 (1 days ago)
Pay Date Fri, Dec 6, 2019
History 204 Payments (Quarterly)
AMGN ChartsAll Time High $225.26 on Tue, Nov 12, 2019.
May 15, 2019
Nov 12, 2019
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.